nitrendipine has been researched along with isradipine in 69 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (33.33) | 18.7374 |
1990's | 35 (50.72) | 18.2507 |
2000's | 6 (8.70) | 29.6817 |
2010's | 5 (7.25) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dietel, M; Höllt, V; Kouba, M; Vogt, G | 1 |
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Einzinger, U; Hoda, JC; Huber, IG; Koschak, A; Obermair, GJ; Sartori, SB; Sinnegger-Brauns, MJ; Striessnig, J; Wild, C | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Reimão, JQ; Scotti, MT; Tempone, AG | 1 |
Sun, H | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Blanck, TJ; Fiskum, G; Hoehner, PJ; Rosenthal, RE; Roy, R | 1 |
Babcock, DF; Corron, ME; Florman, HM; Kim, TD | 1 |
Mason, RP; Moisey, DM; Shajenko, L | 1 |
Bladen, C; Dunn, SM | 1 |
Chou, MY; Shibuya, T; Watanabe, Y | 1 |
Little, HJ; Littleton, JM; Whittington, MA | 1 |
Battaini, F; Bergamaschi, S; Govoni, S; Meucci, O; Parenti, M; Schettini, G; Trabucchi, M | 1 |
Lepor, H; Rosenthal, E; Shapiro, E | 1 |
de Pascual, R; Gandía, L; García, AG; López, MG; Michelena, P | 1 |
Fujimoto, M; Mihara, S | 1 |
Butterworth, AR; Dolin, SJ; Little, HJ; Patch, TL; Siarey, RJ; Whittington, MA | 1 |
Murphy, BJ; Tuana, BS | 1 |
Pinchuk, GV; Pinchuk, LN; Rudenko, AE; Tkachenko, YV | 1 |
Rampe, D; Schilling, WP; Zaher, MC | 1 |
Böhm, M; Erdmann, E; Schwinger, RH | 1 |
Bristow, MR; Minobe, W; Rasmussen, RP | 1 |
Barradas, J; Gerbeau, C | 1 |
Hosey, MM; McMahon, KK; Ptasienski, J | 1 |
Benavides, J; Bertrand, P; Burgevin, MC; Doble, A; Ferris, O; Gueremy, C; Le Fur, G; Menager, J; Uzan, A; Vaucher, N | 1 |
Carpenter, CL; Greenberg, DA; Messing, RO | 1 |
Hosey, MM; Maan, AC; Ptasienski, J | 1 |
Brown, AM; Brush, K; Hamilton, SL; Schwartz, A; Yatani, A | 1 |
Brown, AM; Hamilton, SL; Hawkes, MJ; Kunze, DL | 1 |
DeRoth, L; Godfraind, T; Wibo, M | 1 |
Brown, AM; Kunze, DL; Yatani, A | 1 |
Askanas, V; Desnuelle, C; Engel, WK | 1 |
Massieu, L; Tapia, R | 1 |
Dunn, SM | 2 |
Callens, F; Charlemagne, D; Mayoux, E; Swynghedauw, B | 1 |
Aonuma, S; Fujisue, T; Ichida, S; Masada, A; Matsuda, N; Oda, Y | 1 |
Dodd, PR; Gundlach, AL; Harper, CG; Johnston, GA; Kril, JJ | 1 |
Ehrhardt, JD; Quennedey, MC; Rouot, B; Schwartz, J; Welsch, M | 1 |
Ferry, DR; Glossmann, H; Goll, A; Linn, T | 1 |
Leysen, JE; Pauwels, PJ; Van Assouw, HP | 1 |
Schilling, WP | 1 |
Navarro, J | 1 |
Oswald, RE; Weiland, GA | 1 |
Lee, HR; Roeske, WR; Yamamura, HI | 1 |
Ferry, DR; Glossmann, H; Goll, A | 1 |
Artalejo, CR; Cillero, FJ; de Casa-Juana, MF; de Pascual, R; García, AG; González-Morales, MA; López, MG; Priego, J; Sunkel, C; Villarroya, M | 1 |
Cross, AJ; Green, AR; Little, HJ; Misra, A; Watson, WP | 1 |
Kamp, TJ; Marbán, E; Pérez-García, MT | 1 |
Corbett, AM; Kramer, JW | 1 |
Akimoto, T; Ichida, S; Kishino, H; Matsuda, N; Nakazaki, S; Wada, T | 1 |
Fetkovska, N; Jakubovska, Z; Oravcova, J; Tison, P; Ulicna, L | 2 |
Ganunis, TF; Helfaer, MA; Hoehner, PJ; Kirsch, JR; Murphy, MT; Traystman, RJ | 1 |
Baraldi, M; Brandoli, C; di Bella, M; Parenti, C; Tait, A; Truzzi, C; Veneri, C; Zanoli, P | 1 |
Buxton, BF; Casley, D; Dauer, R; Gallicchio, M; Johnston, CI; Liu, JJ; Wojta, J | 1 |
Blanck, TJ; Fiskum, G; Fox, LG; Hoehner, PJ; Hurt, KJ; Rosenthal, RE; Werling, LL | 1 |
Burger, KJ; Lohmann, FW; Welzel, D | 1 |
Latifpour, J; Weiss, RM; Yoshida, M | 1 |
Fetkovska, N; Jakubovska, Z; Oravcova, J; Tison, P; Trnovec, T; Ulicna, L | 1 |
Ader, JL; Durand, D; Lloveras, JJ; Rostaing, L; Suc, JM; Tack, I; Tran-Van, T | 1 |
Gilar, M; Tesarová, E; Uhrová, M | 1 |
Brauns, T; Glossmann, H; Haugland, RP; Kimball, SD; Prinz, H; Striessnig, J | 1 |
Babcock, DF; Hille, B; Wennemuth, G; Westenbroek, RE; Xu, T | 1 |
Beydemir, S; Söyüt, H; Türkeş, C | 1 |
5 trial(s) available for nitrendipine and isradipine
Article | Year |
---|---|
Effects of dihydropyridines and their combination with aspirin on blood pressure and circadian platelet activity in patients with essential hypertension.
Topics: Adult; Aspirin; Blood Platelets; Blood Pressure; Circadian Rhythm; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Nitrendipine | 1994 |
Treatment of hypertension with dihydropyridine calcium antagonists and aspirin.
Topics: Adult; Aspirin; Blood Platelets; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Nitrendipine | 1994 |
[Circadian antihypertensive action and tolerability of a sustained-release form of isradipine in an intra-individual comparison with nitrendipine].
Topics: Adolescent; Adult; Aged; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Nitrendipine | 1993 |
Treatment of hypertension with calcium antagonists and aspirin. Effects on 24-h platelet activity.
Topics: Adult; Aspirin; Circadian Rhythm; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Nitrendipine; Platelet Aggregation; Treatment Outcome | 1993 |
Renal functional reserve in calcium channel blocker-treated hypertensive recipients of kidney transplant.
Topics: Adult; Amino Acids; Calcium Channel Blockers; Cyclosporine; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Isradipine; Kidney Transplantation; Male; Middle Aged; Nifedipine; Nitrendipine; Renal Plasma Flow; Retrospective Studies | 1995 |
64 other study(ies) available for nitrendipine and isradipine
Article | Year |
---|---|
Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Biological Transport; Calcium Channel Blockers; Cell Line; Dihydropyridines; Drug Resistance; Haplorhini; Immunoblotting; Membrane Glycoproteins; Mice; RNA, Messenger; Stereoisomerism; Verapamil; Vinblastine | 1992 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms.
Topics: Amino Acid Motifs; Animals; Brain; Calcium Channels, L-Type; Dihydropyridines; Female; Gene Expression; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Protein Isoforms | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Anti-leishmanial and anti-trypanosomal activities of 1,4-dihydropyridines: In vitro evaluation and structure-activity relationship study.
Topics: Animals; Antiprotozoal Agents; Cell Line; Cricetinae; Dihydropyridines; Erythrocytes; Leishmania; Macaca mulatta; Mice; Parasitic Sensitivity Tests; Quantitative Structure-Activity Relationship; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Capture hydrolysis signals in the microsomal stability assay: molecular mechanisms of the alkyl ester drug and prodrug metabolism.
Topics: Carboxylic Acids; Cytochrome P-450 Enzyme System; Esters; Humans; Hydrolysis; Microsomes; Models, Molecular; Molecular Structure; Prodrugs; Quantum Theory; Signal Transduction | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Alteration of voltage-dependent calcium channels in canine brain during global ischemia and reperfusion.
Topics: Animals; Binding Sites; Brain Ischemia; Calcium Channel Blockers; Calcium Channels; Cerebral Cortex; Dihydropyridines; Dogs; Female; Isradipine; Nitrendipine; Reperfusion; Synaptosomes | 1992 |
Activation of voltage-dependent calcium channels of mammalian sperm is required for zona pellucida-induced acrosomal exocytosis.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acrosome; Animals; Binding Sites; Calcium Channel Blockers; Calcium Channels; Cattle; Dihydropyridines; Exocytosis; Isradipine; Male; Mice; Nitrendipine; Sheep; Spermatozoa; Zona Pellucida | 1992 |
Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Cattle; Cell Membrane; Cholesterol; Dihydropyridines; Diltiazem; Electrons; Isradipine; Lipid Bilayers; Myocardium; Nifedipine; Nimodipine; Nitrendipine; Phosphatidylcholines; Rabbits; Verapamil | 1992 |
Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Diphosphate; Isradipine; Kinetics; Ligands; Membrane Proteins; Microsomes; Muscles; Nitrendipine; Oxadiazoles; Rabbits; Receptors, Nicotinic; Stereoisomerism; Thionucleotides | 1991 |
Neuropsychopharmacological studies of a Ca2+ channel blocker on the modulation of brain Ca2+ mobilization of spontaneously hypertensive rats under mild stress.
Topics: Acoustic Stimulation; Animals; Binding Sites; Brain; Calcium; Calcium Channel Blockers; Calcium Channels; Cerebral Cortex; Diazepam; Dihydropyridines; Hippocampus; Isoindoles; Isradipine; Kinetics; Male; Motor Activity; Nitrendipine; Organ Specificity; Piperazines; Pyrimidines; Rats; Rats, Inbred SHR; Reference Values; Stress, Psychological; Synaptosomes | 1991 |
Effects of dihydropyridine calcium channel antagonists in ethanol withdrawal; doses required, stereospecificity and actions of Bay K 8644.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Blockers; Dose-Response Relationship, Drug; Ethanol; Isradipine; Male; Mice; Nimodipine; Nitrendipine; Oxadiazoles; Stereoisomerism; Substance Withdrawal Syndrome; Time Factors | 1990 |
Modulation of dihydropyridine-sensitive calcium channels: a role for G proteins.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channels; Dihydropyridines; GTP-Binding Proteins; Guanosine Triphosphate; Isradipine; Neurons; Nitrendipine; Oxadiazoles; Rats; Tumor Cells, Cultured | 1990 |
Characterization of 1,4, dihydropyridine calcium channel binding sites in the human prostate.
Topics: Binding Sites; Calcium Channel Blockers; Calcium Channels; Humans; In Vitro Techniques; Isradipine; Male; Nitrendipine; Oxadiazoles; Prostate; Prostatic Hyperplasia; Receptors, Nicotinic | 1990 |
Different sensitivities to dihydropyridines of catecholamine release from cat and ox adrenals.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenal Glands; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Catecholamines; Cats; Cattle; Dihydropyridines; In Vitro Techniques; Isradipine; Male; Nitrendipine; Perfusion; Species Specificity | 1990 |
Effect of S-312, a new calcium channel blocker, on the 1,4-dihydropyridine binding sites in porcine basilar blood vessels and rat aortic smooth muscle cells.
Topics: Animals; Aorta; Basilar Artery; Binding Sites; Calcium; Calcium Channel Blockers; Cells, Cultured; Dihydropyridines; Isradipine; Muscle, Smooth, Vascular; Nicardipine; Nitrendipine; Oxadiazoles; Rats; Swine | 1991 |
Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptations to, chronic ethanol treatment.
Topics: Adaptation, Psychological; Administration, Inhalation; Animals; Behavior, Animal; Bicuculline; Brain; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Ethanol; Isradipine; Male; Mice; Mice, Inbred C57BL; Nimodipine; Nitrendipine; Seizures; Substance Withdrawal Syndrome | 1991 |
Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
Topics: Allosteric Regulation; Aniline Compounds; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Heart; In Vitro Techniques; Isradipine; Kinetics; Muscles; Myocardium; Nitrendipine; Oxadiazoles; Rabbits; Receptors, Nicotinic; Sarcolemma; Verapamil | 1990 |
Calcium channel ligand binding to intact, concanavalin A and cyclic AMP-treated cells of the immune system.
Topics: Animals; Bucladesine; Calcium Channels; Concanavalin A; Isradipine; Leukocytes, Mononuclear; Lymphocyte Activation; Mice; Mice, Inbred CBA; Nitrendipine; Oxadiazoles; Spleen; Verapamil | 1990 |
Effect of inorganic calcium channel blockers on dihydropyridine binding to cardiac sarcolemma.
Topics: Animals; Cadmium; Calcimycin; Calcium; Calcium Channel Blockers; Dihydropyridines; Dogs; In Vitro Techniques; Isradipine; Lanthanum; Myocardium; Nitrendipine; Ouabain; Oxadiazoles; Quinuclidinyl Benzilate; Sarcolemma | 1990 |
Different negative inotropic activity of Ca2(+)-antagonists in human myocardial tissue.
Topics: Calcium Channel Blockers; Depression, Chemical; Diltiazem; Heart Atria; Heart Failure; Heart Transplantation; Humans; Isradipine; Myocardial Contraction; Nifedipine; Nitrendipine; Papillary Muscles; Pyridines; Verapamil | 1990 |
Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.
Topics: Calcium Channel Blockers; Calcium Channels; Cardiomyopathy, Dilated; Cell Membrane; Humans; Iodocyanopindolol; Isradipine; Kinetics; Myocardium; Nitrendipine; Oxadiazoles; Pindolol; Receptors, Adrenergic, beta; Receptors, Nicotinic | 1990 |
A radioreceptor assay for determination of nicardipine in human serum using 3H(+)PN 200-110 as radioligand.
Topics: Animals; Binding, Competitive; Calcium Channels; Humans; In Vitro Techniques; Isradipine; Kinetics; Male; Nicardipine; Nitrendipine; Oxadiazoles; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Nicotinic; Reproducibility of Results; Stereoisomerism; Tritium | 1990 |
High and low affinity states of the dihydropyridine and phenylalkylamine receptors on the cardiac calcium channel and their interconversion by divalent cations.
Topics: Animals; Calcium; Cations, Divalent; Chickens; Dihydropyridines; Heart; Ion Channels; Isradipine; Magnesium; Myocardium; Nifedipine; Nitrendipine; Oxadiazoles; Pyridines; Receptors, Drug; Verapamil | 1985 |
Dihydropyridine and peripheral type benzodiazepine binding sites: subcellular distribution and molecular size determination.
Topics: Animals; Benzodiazepinones; Binding Sites; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Fractionation; Dogs; Ion Channels; Isoquinolines; Isradipine; Male; Molecular Weight; Myocardium; Nifedipine; Nitrendipine; Oxadiazoles; Rats; Rats, Inbred Strains; Receptors, GABA-A; Receptors, Nicotinic; Sarcolemma; Sarcoplasmic Reticulum; Verapamil | 1985 |
Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcium; Calcium Channel Blockers; Cells, Cultured; Isradipine; Kinetics; Membrane Potentials; Nifedipine; Nitrendipine; Onium Compounds; Organophosphorus Compounds; Oxadiazoles; Potassium; Pyridines; Tritium | 1986 |
Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channels; Chickens; Diltiazem; Dose-Response Relationship, Drug; Ion Channels; Isradipine; Magnesium; Membranes; Muscles; Myocardium; Nitrendipine; Oxadiazoles; Receptors, Nicotinic | 1986 |
A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Dihydropyridines; Guinea Pigs; Heart; Ion Channels; Isradipine; Kinetics; Membrane Potentials; Membranes; Myocardium; Nicotinic Acids; Nimodipine; Nitrendipine; Oxadiazoles; Pyridines; Stereoisomerism; Structure-Activity Relationship | 1987 |
Dihydropyridine binding and calcium channel function in clonal rat adrenal medullary tumor cells.
Topics: Adrenal Gland Neoplasms; Animals; Calcium; Cell Membrane; Clone Cells; Electrophysiology; Ion Channels; Isradipine; Mathematics; Membrane Potentials; Nitrendipine; Oxadiazoles; Pheochromocytoma; Rats | 1987 |
Pharmacologic relevance of dihydropyridine binding sites in membranes from rat aorta: kinetic and equilibrium studies.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Binding, Competitive; Calcium; Calcium Channels; Ion Channels; Isradipine; Kinetics; Muscle, Smooth, Vascular; Nifedipine; Nisoldipine; Nitrendipine; Oxadiazoles; Rats; Rats, Inbred Strains; Receptors, Nicotinic; Stereoisomerism | 1988 |
Effects of dihydropyridine calcium channel modulators on cardiac sodium channels.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channels; Heart; Ion Channels; Isradipine; Myocardium; Nitrendipine; Oxadiazoles; Rats; Receptors, Nicotinic; Sodium; Stereoisomerism | 1988 |
Dihydropyridine-sensitive Ca2+ channel in aneurally cultured human muscles. Relationship between high-affinity binding site and inhibition of calcium uptake.
Topics: Calcium; Calcium Channel Blockers; Calcium Radioisotopes; Cells, Cultured; Dihydropyridines; Electrophysiology; Humans; Ion Channels; Isradipine; Muscles; Nitrendipine; Oxadiazoles; Potassium | 1988 |
Relationship of dihydropyridine binding sites with calcium-dependent neurotransmitter release in synaptosomes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 4-Aminopyridine; Aminopyridines; Animals; Brain; Calcium; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; gamma-Aminobutyric Acid; Ion Channels; Isradipine; Lanthanum; Male; Mice; Neurotransmitter Agents; Nifedipine; Nitrendipine; Oxadiazoles; Potassium; Receptors, Nicotinic; Ruthenium Red; Synaptosomes | 1988 |
Multiple calcium channels in synaptosomes: voltage dependence of 1,4-dihydropyridine binding and effects on function.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Dihydropyridines; Ion Channels; Isradipine; Kinetics; Male; Nitrendipine; Oxadiazoles; Rats; Rats, Inbred Strains; Spectrometry, Fluorescence; Synaptosomes; Verapamil | 1988 |
Adaptational process of the cardiac Ca2+ channels to pressure overload: biochemical and physiological properties of the dihydropyridine receptors in normal and hypertrophied rat hearts.
Topics: Adaptation, Physiological; Animals; Binding, Competitive; Calcium Channel Blockers; Calcium Channels; Cardiomegaly; Heart; In Vitro Techniques; Isradipine; Kinetics; Male; Myocardium; Nitrendipine; Oxadiazoles; Rats; Rats, Inbred Strains; Receptors, Nicotinic; Sarcolemma | 1988 |
Voltage-dependent calcium channels in skeletal muscle transverse tubules. Measurements of calcium efflux in membrane vesicles.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Benzothiazoles; Calcium Channel Blockers; Calcium Channels; Calcium Radioisotopes; Carbocyanines; Cell Membrane; Dihydropyridines; Edetic Acid; Fluorescent Dyes; Isradipine; Lanthanum; Membrane Potentials; Muscles; Nitrendipine; Oxadiazoles; Potassium; Rabbits; Verapamil | 1989 |
Characteristics of specific bindings of nitrendipine and PN200-110 to various crude membranes: induction of irreversible bindings by UV irradiation.
Topics: Animals; Calcium Channel Blockers; Female; In Vitro Techniques; Isradipine; Male; Membranes; Muscle, Smooth; Muscles; Nitrendipine; Oxadiazoles; Rats; Rats, Inbred Strains; Spectrophotometry, Ultraviolet; Time Factors; Ultraviolet Rays | 1989 |
Cortical dihydropyridine binding sites are unaltered in human alcoholic brain.
Topics: Alcoholism; Cerebral Cortex; Dihydropyridines; Humans; Isradipine; Male; Middle Aged; Nitrendipine; Oxadiazoles | 1989 |
Improved radioreceptor assay for the determination of plasma levels of dihydropyridine calcium channel blockers in humans.
Topics: Animals; Calcium Channel Blockers; Dihydropyridines; Isradipine; Male; Mass Spectrometry; Nicardipine; Nitrendipine; Pyridines; Radioligand Assay; Rats; Rats, Inbred Strains | 1989 |
Molecular approach to the calcium channel.
Topics: Animals; Benzothiazoles; Binding Sites; Brain; Calcium; Cattle; Chemical Phenomena; Chemistry; Diltiazem; Guinea Pigs; In Vitro Techniques; Ion Channels; Isradipine; Muscles; Myocardium; Nicotinic Acids; Nifedipine; Nimodipine; Nitrendipine; Oxadiazoles; Thiazoles; Verapamil | 1985 |
Depolarization of chick myotubes triggers the appearance of (+)-[3H]PN 200-110-binding sites.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Chick Embryo; Isradipine; Muscles; Nitrendipine; Oxadiazoles; Receptors, Nicotinic | 1987 |
Effect of divalent cation chelation on dihydropyridine binding in isolated cardiac sarcolemma vesicles.
Topics: Animals; Calcimycin; Calcium; Cations, Divalent; Dihydropyridines; Dogs; Edetic Acid; Hydrogen-Ion Concentration; Isradipine; Magnesium; Myocardium; Nitrendipine; Ouabain; Oxadiazoles; Phosphates; Sarcolemma | 1988 |
Dihydropyridine [methyl-3H]PN 200-110 binding and myogenesis in intact muscle cells in vitro.
Topics: Aminoquinolines; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Chick Embryo; Isradipine; Kinetics; Muscles; Nifedipine; Nitrendipine; Oxadiazoles; Receptors, Nicotinic | 1986 |
The mechanism of binding of dihydropyridine calcium channel blockers to rat brain membranes.
Topics: Animals; Brain; Calcium Channel Blockers; Isomerism; Isradipine; Kinetics; Mathematics; Nifedipine; Nitrendipine; Oxadiazoles; Rats; Rats, Inbred Strains; Time Factors | 1985 |
High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
Topics: Animals; Binding, Competitive; Calcium; Calcium Channel Blockers; Calcium Channels; Cerebral Cortex; Ion Channels; Isradipine; Kinetics; Male; Myocardium; Nifedipine; Nitrendipine; Oxadiazoles; Rats; Rats, Inbred Strains; Receptors, Nicotinic | 1984 |
Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
Topics: Animals; Calcium Channel Blockers; Guinea Pigs; In Vitro Techniques; Ion Channels; Isradipine; Kinetics; Muscles; Nicotinic Acids; Nifedipine; Nimodipine; Nitrendipine; Oxadiazoles | 1983 |
PCA 50941, a novel Ca2+ channel agonist.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Calcium Channel Agonists; Cardiovascular System; Dihydropyridines; Heart Atria; In Vitro Techniques; Isradipine; Mesenteric Arteries; Muscles; Nitrendipine; Rabbits; Rats; Rats, Sprague-Dawley; Swine; Thiazoles; Vasoconstriction | 1993 |
The differential effects of felodipine and nitrendipine on cerebral dihydropyridine binding ex vivo and the ethanol withdrawal syndrome in mice.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Bicuculline; Binding Sites; Brain; Ethanol; Felodipine; Isradipine; Male; Mice; Nitrendipine; Substance Withdrawal Syndrome | 1994 |
Functional properties of cardiac L-type calcium channels transiently expressed in HEK293 cells. Roles of alpha 1 and beta subunits.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Barium; Calcium; Calcium Channels; Calcium Channels, L-Type; Cells, Cultured; Electrophysiology; Humans; Isradipine; Kinetics; Muscle Proteins; Myocardium; Nitrendipine; Time Factors; Transfection | 1995 |
The voltage dependence of depolarization-induced calcium release in isolated skeletal muscle triads.
Topics: Adenosine Triphosphate; Animals; Benzothiazoles; Calcium; Carbocyanines; Fluorescent Dyes; In Vitro Techniques; Isradipine; Kinetics; Membrane Potentials; Muscle, Skeletal; Nitrendipine; Potassium; Rabbits; Ryanodine; Signal Transduction; Spectrometry, Fluorescence; Tritium | 1995 |
Specific bindings of [3H](+)PN200-110 and [125I]omega-conotoxin to crude membranes from differentiated NG108-15 cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Brain; Bucladesine; Cell Differentiation; Cell Membrane; Diltiazem; Glioma; Hybrid Cells; Isradipine; Mollusk Venoms; Neuroblastoma; Nitrendipine; omega-Conotoxin GVIA; Potassium Chloride; Rats; Tumor Cells, Cultured; Verapamil | 1993 |
Dihydropyridine ligand binding decreases earlier in adolescent than in infant swine after global cerebral ischemia.
Topics: Aging; Animals; Blood Pressure; Brain Ischemia; Calcium Channels; Caudate Nucleus; Cerebral Cortex; Dihydropyridines; Hippocampus; Isradipine; Ligands; Membrane Proteins; Nitrendipine; Protein Binding; Swine; Synaptosomes; Time Factors | 1994 |
Synthesis and antiinflammatory activity of 2,6-bis(1,1-dimethylethyl)phenol derivatives.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Calcium; Carrageenan; Edema; Female; Isradipine; Male; Nitrendipine; Phenols; Rats; Rats, Sprague-Dawley; Synaptosomes | 1993 |
Effects of calcium- and ETA-receptor antagonists on endothelin-induced vasoconstriction and levels of endothelin in the human internal mammary artery.
Topics: Calcium Channel Blockers; Cells, Cultured; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Endothelium, Vascular; Humans; In Vitro Techniques; Isradipine; Mammary Arteries; Muscle Relaxation; Muscle, Smooth, Vascular; Nifedipine; Nisoldipine; Nitrendipine; Peptides, Cyclic; Radioimmunoassay; Vasoconstriction | 1994 |
Increased activation of L-type voltage-dependent calcium channels is associated with glycine enhancement of N-methyl-D-aspartate-stimulated dopamine release in global cerebral ischemia/reperfusion.
Topics: Animals; Brain Ischemia; Calcium Channels; Dogs; Dopamine; Female; Glycine; Isradipine; N-Methylaspartate; Nitrendipine; Reperfusion Injury; Time Factors; Tritium | 1994 |
Age-related changes in Ca2+ channel antagonist receptors in rabbit lower urinary tract.
Topics: Aging; Animals; Animals, Newborn; Body Weight; Calcium Channel Agonists; Calcium Channels; Female; In Vitro Techniques; Isradipine; Male; Muscle, Smooth; Nitrendipine; Organ Size; Rabbits; Urethra; Urinary Bladder; Urinary Tract | 1993 |
Enantiomer separation of dihydropyridine calcium antagonists with cyclodextrins as chiral selectors: structural correlation.
Topics: Amlodipine; Buffers; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Cyclodextrins; Dihydropyridines; Electrolytes; Electrophoresis, Capillary; Isradipine; Microspheres; Molecular Conformation; Nimodipine; Nisoldipine; Nitrendipine; Sodium Dodecyl Sulfate; Solvents; Stereoisomerism; Surface-Active Agents | 1996 |
L-type calcium channels: binding domains for dihydropyridines and benzothiazepines are located in close proximity to each other.
Topics: Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Diltiazem; Fluorescent Dyes; Isomerism; Isradipine; Kinetics; Nicotinic Acids; Nifedipine; Nitrendipine; Oxadiazoles; Rabbits | 1997 |
CaV2.2 and CaV2.3 (N- and R-type) Ca2+ channels in depolarization-evoked entry of Ca2+ into mouse sperm.
Topics: Animals; Cadmium; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Calcium Channels, R-Type; Calcium Signaling; Ion Channel Gating; Isradipine; Kinetics; Male; Membrane Potentials; Mibefradil; Mice; Neurotoxins; Nickel; Nitrendipine; omega-Conotoxin GVIA; omega-Conotoxins; Scorpion Venoms; Spermatozoa | 2000 |
Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress.
Topics: Amlodipine; Aryldialkylphosphatase; Calcium Channel Blockers; Humans; Isradipine; Nifedipine; Nitrendipine; Oxidative Stress | 2014 |